Related Experiment Video
Updated: Jan 8, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
Published on: June 14, 2020
Basic Science and Pathogenesis
Matías Ignacio Lantadilla Brito1, Jonhatan Gomez2, Carol D SanMartín1
1Universidad de Chile, Santiago, Santiago, Chile.
Background:
Alzheimer's disease is related to hippocampal neurodegeneration induced by toxic soluble oligomers of beta-amyloid peptides (AβOs) with molecular mechanisms such as increased intracellular calcium concentration, mitochondrial fragmentation, and mitochondrial ROS production. Fungus that inhabit extreme environments of low temperatures, high radiation levels, high dryness, and high-speed winds, like Antarctica and Andean-Patagonia, achieve their adaptation by producing unique secondary metabolites. Some of these molecules have bioactive effects and may exhibit potential neuroprotective effects.
Method:
Fungus extracts were provided by the Applied and Sustainable Chemistry Laboratory (LabQAS), Universidad del Bio-Bio and R/S enantiomers of fommanoxin (FMX) were synthesized by Enamine (Kyiv, UKR). The effects of different Antarctic fungus extract (≈15) on the cell viability of primary rat hippocampal cultures (15 DIV) at different concentrations were tested. After 24 hours of incubation, the viability was measured using the MTT assay. Cultures were treated with fungus extracts at non-lethal concentrations or fommanoxin for neuroprotection assays and co-incubated 2 µM AβOs over 24 hours, followed by an MTT assay. For immunofluorescence, FMX 10 µM of both enantiomers were co-incubated with 1 µM AβOs over 24 hours, followed by fixation and labeling with anti-mHsp70. For calcium signals, 0,01 mg/mL of extract 1832 was preincubated over 24 hours, then loaded with Fluo4-AM, and 500 nM AβOs were used for stimulation at the microscope.
Result:
Fommanoxin protected against the cytotoxic effects of AβOs without differences between the enantiomers, and preliminary results show a reduction in mitochondrial fragmentation. Fungus extracts don't show toxicity at low concentrations, but some are toxic at high concentrations. Extracts 1832 and 1834 show significant protection against the cytotoxic effects of AβOs, and Extract 1832 exhibits a dose-dependent neuroprotective effect. Preliminary extract 1832 also show a reduction in the increase of cytoplasmic concentrations of Ca2+.
Conclusion:
Fommanoxin, extracts 1832 and 1834 have neuroprotection against AβOs toxicity. In addition and preliminary, FMX reduces the mitochondrial network fragmentation, and extract 1832 reduces the increase of cytoplasmic concentrations of Ca2+, both effects induced by AβOs. The study of antarctical fungi extracts must continue to determine the possible molecular mechanisms involved in neuroprotection.
Related Concept Videos
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Urinary Tract Infection II: Pathophysiology
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Pneumonia II: Pathophysiology
Stages of Infection
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

